Latest GlaxoSmithKline Stories
CHICAGO, March 27, 2014 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMZN, ADBE, PETM, GSK, and DG. To see what our analysts have discovered about these stocks
MOON TOWNSHIP, Pa., March 27, 2014 /PRNewswire/ -- GlaxoSmithKline (GSK) Consumer Healthcare is voluntarily recalling all alli® weight loss products from U.S.
Jury awards Mylan $106.7 million in damages PITTSBURGH, March 27, 2014 /PRNewswire/ -- Mylan Inc.
Millions of children in the UK are potentially receiving penicillin prescriptions below the recommended dose for common infections.
MOON TOWNSHIP, Pa., March 26, 2014 /PRNewswire/ -- GlaxoSmithKline (GSK) is alerting consumers that some bottles of its alli® over-the-counter weight loss medication have been tampered with.
New business unit focuses on consumer collaboration and co-creation in the health care industry BOSTON, March 25, 2014 /PRNewswire/ --
DUBLIN, March 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/skgh5l/investigation) has announced the addition of the "Investigation
GlaxoSmithKline said on Thursday that its cancer drug MAGE-A3 has failed its second test. The company said that the drug missed the first co-primary endpoints during the third phase of its study involving more than 2,000 lung cancer patients.
LONDON, March 18, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:
The Majority of Surveyed Oncologists Have Already Prescribed Kadcyla, Just Nine Months Post-Launch, According to Findings from Decision Resources Group BURLINGTON, Mass., March 18, 2014 /PRNewswire/
- A morbid dread of being buried alive. Also spelled 'taphiphobia'.